Price $2.05 |
Market Cap
18.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
237.2
|
P/S
29.62
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-3.7K
|
FCF
-0.4
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-208.80%
|
|
ROA
-477.30%
|
EPS Growth
-39.90%
|
Current Ratio
4.8
|
Debt/Equity
31.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.17 | - | - | 11.3M | Strong Buy |
| Daxor Corporation (DXR) | $6.72 | - | 0.40% | 26.7M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.73 | - | - | 4.7M | Strong Buy |
| Pernix Therapeutics Holdings I (PTX) | $4.59 | - | - | 41.2M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $2.73 | - | - | 6.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
